DNTH
Dianthus Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website dianthustx.com
- Employees(FY) 32
- ISIN US2528281080
Performance
+2.81%
1W
+6.17%
1M
+6.35%
3M
+123.84%
6M
+146.44%
YTD
+149.32%
1Y
Profile
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
Investment Analysis Report: DNTH
Overview:
DNTH is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $706,568,499. In this report, we will conduct a comprehensive analysis of DNTH's financial statements to evaluate its investment potential.
Balance Sheets A...
Technical Analysis of DNTH 2024-05-10
Overview:
In analyzing the technical indicators for DNTH stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...
Recent News & Updates
- 2024-05-09 16:01
- 2024-05-09 10:56
- 2024-05-09 04:01
- 2024-05-08 16:30
- 2024-05-08 04:30
- 2024-05-03 16:30
- 2024-05-03 04:30
- 2024-04-11 07:30
- 2024-04-10 19:30
- 2024-04-05 16:30
- 2024-04-05 04:30
- 2024-03-22 07:55
- 2024-03-21 16:01
- 2024-03-21 10:54
- 2024-03-21 04:01
- 2024-03-07 16:30
- 2024-03-07 03:30
- 2024-02-26 07:00
- 2024-02-25 18:00
- 2024-02-22 19:00
- 2024-01-31 03:05
- 2024-01-21 18:30
- 2024-01-08 06:43
- 2024-01-01 19:30
- 2023-12-13 18:04
- 2023-12-12 05:11
- 2023-11-29 03:05
- 2023-11-09 03:05
- 2023-09-14 05:04
- 2023-08-14 01:35
Page 1 of 5
previousnext